Furthermore, we hypothesize that the crosstalk between NF-κB and NRF2 coordinately regulates NBCn1, thereby integrating antioxidant signaling pathways and suggesting that NBCn1 inhibition might represent a novel strategy to treat lung cancer cells. This evidence concerns the gene SLC4A7 and lung carcinoma.